TECH
BIO-TECHNE Corp
NASDAQ · Healthcare · Biotechnology · US
$72.37
−0.06%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.46
- Revenue estimate
- $292.1M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- $0.52
- EPS estimate
- $0.52
- Revenue actual
- $321.2M
- Revenue estimate
- $314.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +0.8%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $73
- PT range
- $73 – $73
- Analysts
- 10
0 Buy10 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | $0.52 | $0.52 | Beat 0.19% | $321.2M |
| May 6, 2026 | $0.55 | $0.53 | Miss -3.64% | $311.4M |
| Feb 4, 2026 | $0.43 | $0.46 | Beat 6.98% | $295.9M |
| Nov 5, 2025 | $0.42 | $0.42 | Miss -0.33% | $286.6M |
| Aug 6, 2025 | $0.50 | $0.53 | Beat 6.00% | $317.0M |
| May 7, 2025 | $0.51 | $0.56 | Beat 9.80% | $316.2M |
| Feb 5, 2025 | $0.38 | $0.42 | Beat 10.53% | $297.0M |
| Oct 30, 2024 | $0.38 | $0.42 | Beat 10.53% | $289.5M |
| May 1, 2024 | $0.46 | $0.48 | Beat 4.35% | $303.4M |
| Feb 1, 2024 | $0.42 | $0.40 | Miss -4.76% | $272.6M |
| Oct 31, 2023 | $0.44 | $0.41 | Miss -6.82% | $276.9M |
| May 3, 2023 | $0.53 | $0.53 | Miss -0.19% | $294.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026